Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder Cancer.

Saved in:
Bibliographic Details
Title: Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder Cancer.
Authors: Contieri R; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Biochemical Science, Humanitas University, Milan, Italy; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy., Martini A; Department of Urology, University of Cincinnati, Cincinnati, OH, USA., Beijert IJ; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Hentschel AE; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Bründl J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Compérat EM; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France., Plass K; European Association of Urology Guidelines Office, Arnhem, The Netherlands., Rodríguez O; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Subiela Henríquez JD; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Hernández V; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., de la Peña E; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Alemany I; Department of Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Turturica D; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Pisano F; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Čapoun O; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia., Bauerová L; Department of Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia., Pešl M; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia., Maxim Bruins H; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Runneboom W; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Herdegen S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Breyer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Brisuda A; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia., Calatrava A; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Rubio-Briones J; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Seles M; Department of Urology, Medical University of Graz, Graz, Austria., Mannweiler S; Department of Pathology, Medical University of Graz, Graz, Austria., Bosschieter J; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Kusuma VRM; Department of Urology, Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Ashabere D; Department of Urology, Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Huebner N; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Seisen T; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; GRC No. 5 ONCOTYPE-URO, Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France., Claps F; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Masson-Lecomte A; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Saint-Louis Hospital, AP-HP, Paris Cité University, Paris, France., Liedberg F; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Skaanes Universitetssjukhus, Malmö, Sweden., Cohen D; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Royal Free London NHS Foundation Trust, London, UK., Lunelli L; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France., Cussenot O; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France., Sheikh SE; Department of Pathology, Royal Free London NHS Foundation Trust, London, UK., Volanis D; Department of Urology, Royal Free London NHS Foundation Trust, London, UK., Côté JF; Department of Pathology, Pitié Salpétrière Hospital, AP-HP and Pierre et Marie Curie Medical School, Sorbonne University, Paris, France., Rouprêt M; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; GRC No. 5 ONCOTYPE-URO, Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France., Haitel A; Department of Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Shariat SF; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Mostafid AH; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Zigeuner R; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Medical University of Graz, Graz, Austria., Dominguez-Escrig JL; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Hacek J; Department of Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia., Zlotta AR; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada., Burger M; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., Evert M; Department of Pathology, University of Regensburg, Regensburg, Germany., de Kaa CAH; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Kiemeney LALM; IQ Health and Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Soukup V; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia., Molinaro L; Department of Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Hurle R; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy., Paciotti M; Department of Biochemical Science, Humanitas University, Milan, Italy; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy., Moschini M; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Pradere B; Department of Urology UROSUD, La Croix du Sud Hôpital, Quint Fonsegrives, France., Perdonà S; Uro-Gynecological Department, Istituto Nazionale Tumori di Napoli G. Pascale IRCCS, Naples, Italy., Gontero P; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Llorente C; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Algaba F; Department of Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Palou J; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., N'Dow J; European Association of Urology Guidelines Office, Arnhem, The Netherlands., Ribal MJ; European Association of Urology Guidelines Office, Arnhem, The Netherlands., van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada., Babjuk M; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Sylvester RJ; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. Electronic address: b.v.rhijn@nki.nl.
Source: European urology oncology [Eur Urol Oncol] 2025 Aug; Vol. 8 (4), pp. 977-985. Date of Electronic Publication: 2025 May 21.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40399193
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Contieri+R%22">Contieri R</searchLink>; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Biochemical Science, Humanitas University, Milan, Italy; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy.<br /><searchLink fieldCode="AU" term="%22Martini+A%22">Martini A</searchLink>; Department of Urology, University of Cincinnati, Cincinnati, OH, USA.<br /><searchLink fieldCode="AU" term="%22Beijert+IJ%22">Beijert IJ</searchLink>; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Mertens+LS%22">Mertens LS</searchLink>; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hentschel+AE%22">Hentschel AE</searchLink>; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bründl+J%22">Bründl J</searchLink>; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Compérat+EM%22">Compérat EM</searchLink>; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Plass+K%22">Plass K</searchLink>; European Association of Urology Guidelines Office, Arnhem, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Rodríguez+O%22">Rodríguez O</searchLink>; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Subiela+Henríquez+JD%22">Subiela Henríquez JD</searchLink>; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Hernández+V%22">Hernández V</searchLink>; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22de+la+Peña+E%22">de la Peña E</searchLink>; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Alemany+I%22">Alemany I</searchLink>; Department of Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Turturica+D%22">Turturica D</searchLink>; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Pisano+F%22">Pisano F</searchLink>; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Soria+F%22">Soria F</searchLink>; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Čapoun+O%22">Čapoun O</searchLink>; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.<br /><searchLink fieldCode="AU" term="%22Bauerová+L%22">Bauerová L</searchLink>; Department of Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.<br /><searchLink fieldCode="AU" term="%22Pešl+M%22">Pešl M</searchLink>; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.<br /><searchLink fieldCode="AU" term="%22Maxim+Bruins+H%22">Maxim Bruins H</searchLink>; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Runneboom+W%22">Runneboom W</searchLink>; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Herdegen+S%22">Herdegen S</searchLink>; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Breyer+J%22">Breyer J</searchLink>; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Brisuda+A%22">Brisuda A</searchLink>; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia.<br /><searchLink fieldCode="AU" term="%22Calatrava+A%22">Calatrava A</searchLink>; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Rubio-Briones+J%22">Rubio-Briones J</searchLink>; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Seles+M%22">Seles M</searchLink>; Department of Urology, Medical University of Graz, Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Mannweiler+S%22">Mannweiler S</searchLink>; Department of Pathology, Medical University of Graz, Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Bosschieter+J%22">Bosschieter J</searchLink>; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kusuma+VRM%22">Kusuma VRM</searchLink>; Department of Urology, Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.<br /><searchLink fieldCode="AU" term="%22Ashabere+D%22">Ashabere D</searchLink>; Department of Urology, Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.<br /><searchLink fieldCode="AU" term="%22Huebner+N%22">Huebner N</searchLink>; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Seisen+T%22">Seisen T</searchLink>; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; GRC No. 5 ONCOTYPE-URO, Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Claps+F%22">Claps F</searchLink>; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Masson-Lecomte+A%22">Masson-Lecomte A</searchLink>; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Saint-Louis Hospital, AP-HP, Paris Cité University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Liedberg+F%22">Liedberg F</searchLink>; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Skaanes Universitetssjukhus, Malmö, Sweden.<br /><searchLink fieldCode="AU" term="%22Cohen+D%22">Cohen D</searchLink>; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Royal Free London NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Lunelli+L%22">Lunelli L</searchLink>; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Cussenot+O%22">Cussenot O</searchLink>; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Sheikh+SE%22">Sheikh SE</searchLink>; Department of Pathology, Royal Free London NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Volanis+D%22">Volanis D</searchLink>; Department of Urology, Royal Free London NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Côté+JF%22">Côté JF</searchLink>; Department of Pathology, Pitié Salpétrière Hospital, AP-HP and Pierre et Marie Curie Medical School, Sorbonne University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Rouprêt+M%22">Rouprêt M</searchLink>; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; GRC No. 5 ONCOTYPE-URO, Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Haitel+A%22">Haitel A</searchLink>; Department of Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Shariat+SF%22">Shariat SF</searchLink>; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Mostafid+AH%22">Mostafid AH</searchLink>; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.<br /><searchLink fieldCode="AU" term="%22Nieuwenhuijzen+JA%22">Nieuwenhuijzen JA</searchLink>; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Zigeuner+R%22">Zigeuner R</searchLink>; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Medical University of Graz, Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Dominguez-Escrig+JL%22">Dominguez-Escrig JL</searchLink>; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Hacek+J%22">Hacek J</searchLink>; Department of Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia.<br /><searchLink fieldCode="AU" term="%22Zlotta+AR%22">Zlotta AR</searchLink>; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Burger+M%22">Burger M</searchLink>; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Evert+M%22">Evert M</searchLink>; Department of Pathology, University of Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22de+Kaa+CAH%22">de Kaa CAH</searchLink>; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Heijden+AG%22">van der Heijden AG</searchLink>; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kiemeney+LALM%22">Kiemeney LALM</searchLink>; IQ Health and Urology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Soukup+V%22">Soukup V</searchLink>; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.<br /><searchLink fieldCode="AU" term="%22Molinaro+L%22">Molinaro L</searchLink>; Department of Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Hurle+R%22">Hurle R</searchLink>; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy.<br /><searchLink fieldCode="AU" term="%22Paciotti+M%22">Paciotti M</searchLink>; Department of Biochemical Science, Humanitas University, Milan, Italy; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy.<br /><searchLink fieldCode="AU" term="%22Moschini+M%22">Moschini M</searchLink>; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Pradere+B%22">Pradere B</searchLink>; Department of Urology UROSUD, La Croix du Sud Hôpital, Quint Fonsegrives, France.<br /><searchLink fieldCode="AU" term="%22Perdonà+S%22">Perdonà S</searchLink>; Uro-Gynecological Department, Istituto Nazionale Tumori di Napoli G. Pascale IRCCS, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Gontero+P%22">Gontero P</searchLink>; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Llorente+C%22">Llorente C</searchLink>; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Algaba+F%22">Algaba F</searchLink>; Department of Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Palou+J%22">Palou J</searchLink>; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22N'Dow+J%22">N'Dow J</searchLink>; European Association of Urology Guidelines Office, Arnhem, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Ribal+MJ%22">Ribal MJ</searchLink>; European Association of Urology Guidelines Office, Arnhem, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Kwast+TH%22">van der Kwast TH</searchLink>; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Babjuk+M%22">Babjuk M</searchLink>; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Sylvester+RJ%22">Sylvester RJ</searchLink>; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Rhijn+BWG%22">van Rhijn BWG</searchLink>; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. Electronic address: b.v.rhijn@nki.nl.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101724904%22">European urology oncology</searchLink> [Eur Urol Oncol] 2025 Aug; Vol. 8 (4), pp. 977-985. <i>Date of Electronic Publication: </i>2025 May 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101724904 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2588-9311 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225889311%22">25889311 </searchLink><i>NLM ISO Abbreviation: </i>Eur Urol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40399193
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.euo.2025.04.010
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 977
    Titles:
      – TitleFull: Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Contieri R
      – PersonEntity:
          Name:
            NameFull: Martini A
      – PersonEntity:
          Name:
            NameFull: Beijert IJ
      – PersonEntity:
          Name:
            NameFull: Mertens LS
      – PersonEntity:
          Name:
            NameFull: Hentschel AE
      – PersonEntity:
          Name:
            NameFull: Bründl J
      – PersonEntity:
          Name:
            NameFull: Compérat EM
      – PersonEntity:
          Name:
            NameFull: Plass K
      – PersonEntity:
          Name:
            NameFull: Rodríguez O
      – PersonEntity:
          Name:
            NameFull: Subiela Henríquez JD
      – PersonEntity:
          Name:
            NameFull: Hernández V
      – PersonEntity:
          Name:
            NameFull: de la Peña E
      – PersonEntity:
          Name:
            NameFull: Alemany I
      – PersonEntity:
          Name:
            NameFull: Turturica D
      – PersonEntity:
          Name:
            NameFull: Pisano F
      – PersonEntity:
          Name:
            NameFull: Soria F
      – PersonEntity:
          Name:
            NameFull: Čapoun O
      – PersonEntity:
          Name:
            NameFull: Bauerová L
      – PersonEntity:
          Name:
            NameFull: Pešl M
      – PersonEntity:
          Name:
            NameFull: Maxim Bruins H
      – PersonEntity:
          Name:
            NameFull: Runneboom W
      – PersonEntity:
          Name:
            NameFull: Herdegen S
      – PersonEntity:
          Name:
            NameFull: Breyer J
      – PersonEntity:
          Name:
            NameFull: Brisuda A
      – PersonEntity:
          Name:
            NameFull: Calatrava A
      – PersonEntity:
          Name:
            NameFull: Rubio-Briones J
      – PersonEntity:
          Name:
            NameFull: Seles M
      – PersonEntity:
          Name:
            NameFull: Mannweiler S
      – PersonEntity:
          Name:
            NameFull: Bosschieter J
      – PersonEntity:
          Name:
            NameFull: Kusuma VRM
      – PersonEntity:
          Name:
            NameFull: Ashabere D
      – PersonEntity:
          Name:
            NameFull: Huebner N
      – PersonEntity:
          Name:
            NameFull: Seisen T
      – PersonEntity:
          Name:
            NameFull: Claps F
      – PersonEntity:
          Name:
            NameFull: Masson-Lecomte A
      – PersonEntity:
          Name:
            NameFull: Liedberg F
      – PersonEntity:
          Name:
            NameFull: Cohen D
      – PersonEntity:
          Name:
            NameFull: Lunelli L
      – PersonEntity:
          Name:
            NameFull: Cussenot O
      – PersonEntity:
          Name:
            NameFull: Sheikh SE
      – PersonEntity:
          Name:
            NameFull: Volanis D
      – PersonEntity:
          Name:
            NameFull: Côté JF
      – PersonEntity:
          Name:
            NameFull: Rouprêt M
      – PersonEntity:
          Name:
            NameFull: Haitel A
      – PersonEntity:
          Name:
            NameFull: Shariat SF
      – PersonEntity:
          Name:
            NameFull: Mostafid AH
      – PersonEntity:
          Name:
            NameFull: Nieuwenhuijzen JA
      – PersonEntity:
          Name:
            NameFull: Zigeuner R
      – PersonEntity:
          Name:
            NameFull: Dominguez-Escrig JL
      – PersonEntity:
          Name:
            NameFull: Hacek J
      – PersonEntity:
          Name:
            NameFull: Zlotta AR
      – PersonEntity:
          Name:
            NameFull: Burger M
      – PersonEntity:
          Name:
            NameFull: Evert M
      – PersonEntity:
          Name:
            NameFull: de Kaa CAH
      – PersonEntity:
          Name:
            NameFull: van der Heijden AG
      – PersonEntity:
          Name:
            NameFull: Kiemeney LALM
      – PersonEntity:
          Name:
            NameFull: Soukup V
      – PersonEntity:
          Name:
            NameFull: Molinaro L
      – PersonEntity:
          Name:
            NameFull: Hurle R
      – PersonEntity:
          Name:
            NameFull: Paciotti M
      – PersonEntity:
          Name:
            NameFull: Moschini M
      – PersonEntity:
          Name:
            NameFull: Pradere B
      – PersonEntity:
          Name:
            NameFull: Perdonà S
      – PersonEntity:
          Name:
            NameFull: Gontero P
      – PersonEntity:
          Name:
            NameFull: Llorente C
      – PersonEntity:
          Name:
            NameFull: Algaba F
      – PersonEntity:
          Name:
            NameFull: Palou J
      – PersonEntity:
          Name:
            NameFull: N'Dow J
      – PersonEntity:
          Name:
            NameFull: Ribal MJ
      – PersonEntity:
          Name:
            NameFull: van der Kwast TH
      – PersonEntity:
          Name:
            NameFull: Babjuk M
      – PersonEntity:
          Name:
            NameFull: Sylvester RJ
      – PersonEntity:
          Name:
            NameFull: van Rhijn BWG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2025 Aug
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2588-9311
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: European urology oncology
              Type: main
ResultId 1